05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
Wells Fargo & Co. agreed to pay a total of $3 billion to resolve criminal and civil investigations b...
Read More >
Long before the COVID-19 pandemic, the construction industry was "going global" using available tech...
Read More >
Join Shipman & Goodwin tax attorneys Louis Schatz and David Bigger for this complimentary webinar re...
Read More >
The Internal Revenue Service (IRS) announced today cost-of-living adjustments affecting dollar limit...
Read More >
An employer’s confidentiality and non-disclosure rule and media contact rule do not violate the Nat...
Read More >
Big Tech as well as other global companies will likely have to modify their business models - Japa...
Read More >